SomaLogic to Participate in the 41st Annual J.P. Morgan Healthcare Conference
SomaLogic, a leader in proteomics technology, is set to participate in the 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023, at 11:15 a.m. Pacific Time. The conference will allow interested parties to access a live audio webcast of the presentation via the company's website. SomaLogic focuses on providing actionable health-management information through the measurement of proteins, helping individuals optimize their health over time. For further details, visit SomaLogic's investor page.
- None.
- None.
BOULDER, Colo., Dec. 29, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.
SomaLogic will present at the conference on Thursday, January 12, 2023 at 11:15 a.m. Pacific Time. Interested parties may access a live audio webcast of the presentation by visiting the “Investors” section of the company’s website at https://investors.somalogic.com.
About SomaLogic
SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com and follow @somalogic on Twitter.
Media Contact
Emilia Costales
720-798-5054
ecostales@somalogic.com
Investor Contacts
Marissa Bych
Gilmartin Group LLC
Marissa@gilmartinir.com
FAQ
When will SomaLogic present at the J.P. Morgan Healthcare Conference?
How can I access SomaLogic's presentation at the conference?
What is the focus of SomaLogic's business?
What is the stock symbol for SomaLogic?